Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Report 2026

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Overview

• Messenger ribonucleic acid (mRNA) Synthesis Raw Materials market size has reached to $3.03 billion in 2025 • Expected to grow to $3.65 billion in 2030 at a compound annual growth rate (CAGR) of 4% • Growth Driver: Role Of mRNA Synthesis Raw Materials In Addressing Rising Cancer And Chronic Disorders • Market Trend: New Enzyme Breakthrough Dramatically Reduces dsRNA For Safer mRNA Therapies • North America was the largest region in 2025.

What Is Covered Under Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?

Messenger ribonucleic acid (mRNA) synthesis raw materials are ribonuclear materials that ensure the precise and efficient synthesis of mRNA molecules in in-vitro transcription processes to produce physiologically functioning synthetic RNAs. It is used to produce mRNA vaccines that induce the body to produce an immune response against the antigen, thereby expanding the body's immune capacity. The main mRNA synthesis raw materials include capping agents, nucleotides, plasmid DNA, and others. The capping agent is an amphiphilic molecule with a polar head group and a non-polar hydrocarbon tail that is used to introduce a modified cap structure to an mRNA molecule during mRNA synthesis that gives the mRNA stability and protection, increasing its translation efficiency and resistance to destruction. These are used in various applications such as therapeutics production, vaccine production, and others, and are used by biotechnology companies, pharmaceutical companies, research and academic institutions, and others.

What Is The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Growth Forecast?

The messenger ribonucleic acid (mrna) synthesis raw materials market size is expected to see steady growth in the next few years. It will grow to $3.65 billion in 2030 at a compound annual growth rate (CAGR) of 4.0%. The growth in the forecast period can be attributed to expansion of mrna-based therapeutics, adoption of automated mrna synthesis platforms, increase in personalized medicine initiatives, growth of biotechnology manufacturing hubs, innovations in nucleotide modifications. Major trends in the forecast period include synthetic mrna optimization, high-purity raw material development, scalable in-vitro transcription processes, supply chain standardization for mrna production, quality control & regulatory compliance.

Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Segmentation

1) By Type: Capping Agents, Nucleotides, Plasmid DNA, Other Types 2) By Applications: Therapeutics Production, Vaccine Production, Other Applications 3) By End-Users: Biotechnology Companies, Pharmaceutical Companies, Research And Academic Institutions, Other End-Users Subsegments: 1) By Capping Agents: 7-Methyl Guanylate (M7G) Capping Agents, Other Capping Agents 2) By Nucleotides: Natural Nucleotides, Modified Nucleotides, Triphosphate Nucleotides 3) By Plasmid DNA: Linearized Plasmid DNA, Circular Plasmid DNA, High-Purity Plasmid DNA 4) By Other Types: Buffer Solutions, Enzymes, Other Auxiliary Materials

What Is The Driver Of The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?

The growing incidence of cancer and chronic disorders is expected to propel the growth of the mRNA synthesis raw materials market going forward. Cancer is a disorder in which aberrant cells develop uncontrollably and can infiltrate neighbouring tissues and potentially move to other regions of the body via the blood and lymph systems. Chronic illnesses are described generically as problems that persist for a year or longer, need continuing medical treatment, impede everyday activities, or both. mRNA synthesis raw materials are used in drug discovery, vaccine development, and the manufacturing of therapeutics that are RNA-based to offer better immunogenicity, higher efficiency, and a short production time that can be used to treat cancer and chronic disorders. For instance, in January 2024, according to the data published by the American Cancer Society, a US-based non-profit organization, the United States is projected to see 2,001,140 new cancer cases and 611,720 cancer deaths in 2024, compared to 1,958,310 cases and 609,820 deaths in 2023. Furthermore, in September 2025, according to the British Heart Foundation, a UK-based charity, across the UK, more than 7.6 million people over 4 million men and more than 3.6 million women are living with cardiovascular disease, and projections indicate that, driven by an aging population and improved survival rates, the number of affected individuals may rise by around 1 million by 2030 and by approximately 2 million by 2040. Therefore, the growing incidence of cancer and chronic disorders drives the mRNA synthesis of raw materials.

Key Players In The Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market

Major companies operating in the messenger ribonucleic acid (mrna) synthesis raw materials market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group Ltd., Bio-Rad Laboratories Inc., Qiagen N.V., Maravai LifeSciences, Takara Bio Inc., GenScript Biotech Corporation, Promega Corporation, Integrated DNA Technologies Inc., LGC Biosearch Technologies, Merck KGaA, GeneCopoeia Inc., Bio-Synthesis Inc., BOC Sciences Inc., Bio Basic Inc., OriGene Technologies Inc., BioCat GmbH, Creative Biogene, Jena Bioscience GmbH, ATDBio Ltd.

Global Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Trends and Insights

Major companies operating in the messenger ribonucleic acid (mRNA) synthesis raw materials market are focusing on developing strategic collaborations to enhance their technological capabilities, expand high-quality raw-material portfolios, and accelerate the production of next-generation mRNA therapeutics. Strategic collaborations refer to formal partnerships between biotechnology firms, enzyme developers, and nucleic acid technology providers aimed at co-developing advanced IVT enzymes, modified nucleotides, capping analogs, or other critical inputs that improve mRNA yield, purity, stability, and safety. For instance, in September 2024, TriLink Biotechnologies, a US-based biotechnology company, collaborated with Alphazyme LLC, a US-based custom molecular biology enzyme company, to launch the CleanScribe RNA Polymerase, a next-generation IVT enzyme that reduces double-stranded RNA formation by up to 85% during mRNA synthesis, thereby supporting the development of safer and more potent mRNA therapeutics.

What Are Latest Mergers And Acquisitions In The Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?

In February 2025, Maravai LifeSciences, a U.S.-based life sciences company, acquired the DNA and RNA business of Officinae Bio for an undisclosed amount. Through this acquisition, Maravai LifeSciences aims to strengthen its nucleic acid production portfolio and enhance its support for innovative mRNA and DNA therapeutic development. Officinae Bio is an Italy-based biotechnology company specializing in DNA and RNA technologies for research and therapeutic applications.

Regional Insights

North America was the largest region in the mRNA synthesis raw materials market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market?

The mRNA synthesis raw materials market consists of sales of modified ribonucleoside triphosphates, polynucleotide tails, ribonucleoside diphosphate (NDPs), ribonucleoside monophosphate (NMPs), and ribonucleoside triphosphate (NTTs). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Market Report 2026?

The messenger ribonucleic acid (mrna) synthesis raw materials market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the messenger ribonucleic acid (mrna) synthesis raw materials industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.